Effect of Flunixin on Ovarian Cancer Induced by DMBA in Female Wistar Rats
DOI:
https://doi.org/10.22100/jkh.v7i1.123Keywords:
Ovary cancer, Flunixin, Chemical carcinogen DMBA, Female rats.Abstract
Introduction: Ovary cancer is one of the commonest cancers among the women. With regard to role of cyclooxygnase(COX) enzyme and production of prostaglandin type E2 in causing tumor damages in ovary cancer, application of compounds to inhibit cyclooxygnase can be effective in preventing ovary cancer. Thus, the present study was carried out to evaluate flunixin as nonselective inhibitor of Cyclooxygenase enzymes in developing ovary cancer in female Wistar rats.
Methods: In this experimental research, forty eight female Wistar rats, assigned into six groups, were used. To induce cancer, 7,12 Dimethyl Benza Anthracene was directly injected into ovary. Control groups included a negative control group (no injection), a DMBA injection control group and a positive control group (DMBA+Saline injection). Ten days after administrating DMBA to the tumor, three doses (0.5, 1, 1.5 mg) of flunixin meglumine were injected into the three case groups every third day. The comparison between groups was made by using one-way ANOVA.
Results: The mean weight of tumors significantly decreased in drug receiving groups, compared to positive control and DMBA control groups. The mean weight of ovary in the three groups receiving flunixin did not show any significant difference, compared with the negative control (natural) group (P>0.05).
Conclusion: This study confirms the positive effect of the flunixin in treating the ovary cancer. The microscopic slices of ovary tissues in the experimental (drug receiving) groups indicate that cancerous cells are decreasing so that the cells tend to gain their own normal order again.
References
Moller P, Wallin H, Knudesen LE. Oxidative stress associated psychological stress and life-style factor. Chem Bio Interact 1996;102:1-36.
Staklef F,Von Grueni J. Rodent models ovarian cancer. Int J Gyncol cancer 2003;13:405-412.
Abdul AT, Gopakumaran S, Nair R, Thankappan R, Shankar GSl. Genistei induces apoptosis in ovarian cancer cells different molecular pathways depending on breast cancer susceptibility gene-1(BRCA1) status. Jornal of Pharmacology 2008;58(32):158-164.
Stefania T, Rosamaria P, Alssandro M. Molecular and in silico analysis of BRCA1 and BRCA2 variants. Mutation Research 2008;644:64-70.
Whittle BJ. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 2003;17:301-313.
Teri LL, Marchele N, Shailesh S. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006;6:179-181.
Zhu YM, Azahri NS, Yu DC, Woll PJ. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 2008;8:216-218.
Dormond O, Foletti A, Paroz C, Ruegg C. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat Med 2001;7:1041-1047.
Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000;19:19-27.
Xiao MF, Xiao HJ, Qing Gu, Yick PCh, ManFung Y. Inhibition of AKT/PKB by a COX-2 Inhibitor Induces Apoptosis in Gastric Cancer Cell. Digestion2006;73:75-83.
Flunixin Available [editorial]. Wikipedia Free encyclopedia 2008.
Kayvan K, Mohammad Gh, Vahideh A. Effect of flunixin as a cox inhibitor on prevention and cure of breast cancer in female wistar rat. Ofogh-e-Danesh Gmuhs Journal 2010;26-27.[Persian].
Takafumi K, Susuma T. Effects of dehydrepianresteron and other sex steroid hormones on mammary carcinogenesis by direct inject 7, 12-dimethylbenz(a)ntheracene(DMBA) in hyperoprolactinemitic female rat. Breast Cancer Research and Treatment 1997;43:105-111.
Kankaanranta H, Moilanen E, Vapaatalo H. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions. Inflammation 1993;17(4):417-25.
Liu JZ, Milner JA. Age dietary selenium and quantity of 7, 12-dimethylbenz[a] anthracene influence the invivo occurrence of rat mammary DNA adducts. J Nutr 1992;122(7):381-386.
Robbins K, Fausto M, Gheytasvand M. Robbins basic pathology. Translated to Persian by: Kanani M., 8th ed. 2007.p.316-320.
Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358(19):2039-49.
Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K. The role of angiogenesis in solid tumor: an ovaruiew. Eur J Int Med 2009;20:663-71.
Shimizu.D, Peters.Jh, Vallboehmer.D, Kuramochi.H, Uchida.K. Cyclooxygenase-2 (COX-2) mediated anti-apoptosis may occur via Bcl-2 in the progression of Barrett esophagus to adenocarcinoma. Journal of clinical Oncology 2004;22(14):529-536.
Nurse P. A Long Twentieth Century of the cell Cycle and Beyond. Cell 2000;100:71-78.
Waston D, Baker TA. Molecular Biology of the gen. Cshl Press; 2003.p.33-38.
Corcoran CA, He Q, Huang Y, Sheikh MS. Cyclooxygenase-2 interacts with p53 and interferes with p53- dependent transcription and apoptosis. Oncogene 2005;24:1634-1640.
Choi EM, Heo JI, Oh JY, KimYM, Ha KS, Kim JI, et al. COX-2 regulates P53 activity and inhibits DNA damage-induced apoptosis. Biochem Biophys Res Commun 2005;328(4):1107-12.
Hermanova M, Trna J, Nenutil R, Dite P, Kala Zdenek. Expression of COX-2 and P53 expression in Premalignant and malignant ductal pancreatic. Europen Journal of Gastronterologe & Hepatology 2008;20:732-739.
Holmila R, Cyr D, Luce D, Heikkila P, Dictor M, Steiniche T, et al. COX-2 and P53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure. Int J Cancer 2008;122(9):2154-9.
Dixon MJ. Role of ErbB2 in selection for adjuvant tamoxifen or aromatase inhibitors. Womens Health 2008;14(3):229-31.
Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, et al. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res 2006;66:7059-7066.
Dass CR, Choong PF. Cancer angiogenesis: targeting the heel of Achill. J Drug Target 2008;16(6):449-54.
Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:986-992.
Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci USA 2009;106(9):3372-3377.
Gee J, Lee IL, Jendiroba D, Fischer SM, Grossman HB, Sabichi AL, et al. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Oncol Rep 2006;15:471-477.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
